F-star Alpha's Series A Round

F-star Alpha raised a round of funding on October 23, 2013.

F-star Alpha is a Cambridge UK-based company formed by F-star Biotechnology. F-star Alpha will receive an exclusive licence to FS102, an Fcab antibody fragment, which eliminates HER2-positive cancer c…

Articles about F-star Alpha's Series A Round: